| CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma R Marcus, K Imrie, A Belch, D Cunningham, E Flores, J Catalano, ... Blood 105 (4), 1417-1423, 2005 | 1239 | 2005 |
| Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a … MHJ Van Oers, R Klasa, RE Marcus, M Wolf, E Kimby, RD Gascoyne, ... Blood 108 (10), 3295-3301, 2006 | 768 | 2006 |
| Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma R Marcus, K Imrie, P Solal-Celigny, JV Catalano, A Dmoszynska, ... Journal of Clinical Oncology 26 (28), 4579-4586, 2008 | 759 | 2008 |
| Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H G Hale, MR Clark, R Marcus, G Winter, MJS Dyer, JM Phillips, ... The Lancet 332 (8625), 1394-1399, 1988 | 729 | 1988 |
| Obinutuzumab for the first-line treatment of follicular lymphoma R Marcus, A Davies, K Ando, W Klapper, S Opat, C Owen, E Phillips, ... New England Journal of Medicine 377 (14), 1331-1344, 2017 | 728 | 2017 |
| Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial KM Ardeshna, P Smith, A Norton, BW Hancock, PJ Hoskin, ... The Lancet 362 (9383), 516-522, 2003 | 655 | 2003 |
| Bone marrow transplantation for patients with chronic myeloid leukemia JM Goldman, JF Apperley, L Jones, R Marcus, AWG Goolden, ... New England Journal of Medicine 314 (4), 202-207, 1986 | 516 | 1986 |
| Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation AL Taylor, R Marcus, JA Bradley Critical reviews in oncology/hematology 56 (1), 155-167, 2005 | 491 | 2005 |
| Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and … BB Bjorkstrand, P Ljungman, H Svensson, J Hermans, A Alegre, ... | 446 | 1996 |
| Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the … JF Apperley, L Jones, G Hale, H Waldmann, J Hows, Y Rombos, ... Bone marrow transplantation 1 (1), 53-66, 1986 | 382 | 1986 |
| Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study MHJ Van Oers, M Van Glabbeke, L Giurgea, R Klasa, RE Marcus, M Wolf, ... Journal of clinical oncology 28 (17), 2853, 2010 | 374 | 2010 |
| CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment … J Lundin, A Osterborg, G Brittinger, D Crowther, H Dombret, A Engert, ... Journal of Clinical Oncology 16 (10), 3257-3263, 1998 | 309 | 1998 |
| Ocular toxicity of high-dose intravenous desferrioxamine SC Davies, JL Hungerford, GB Arden, RE Marcus, MH Miller, ER Huehns The Lancet 322 (8343), 181-184, 1983 | 303 | 1983 |
| ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) M Ghielmini, U Vitolo, E Kimby, S Montoto, J Walewski, M Pfreundschuh, ... Annals of oncology 24 (3), 561-576, 2013 | 248 | 2013 |
| Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies P Boraks, J Seale, J Price, G Bass, M Ethell, D Keeling, P Mahendra, ... British Journal of Haematology 101 (3), 483-486, 1998 | 244 | 1998 |
| Diagnosis of post‐transplant lymphoproliferative disorder in solid organ transplant recipients–BCSH and BTS Guidelines A Parker, K Bowles, JA Bradley, V Emery, C Featherstone, G Gupte, ... British journal of haematology 149 (5), 675-692, 2010 | 236 | 2010 |
| Immunochemotherapy with obinutuzumab or rituximab for previously untreated follicular lymphoma in the GALLIUM study: influence of chemotherapy on efficacy and safety W Hiddemann, AM Barbui, MA Canales, PK Cannell, GP Collins, J Dürig, ... Journal of Clinical Oncology, 2395-2404, 2018 | 220 | 2018 |
| Management of post‐transplant lymphoproliferative disorder in adult solid organ transplant recipients–BCSH and BTS Guidelines A Parker, K Bowles, JA Bradley, V Emery, C Featherstone, G Gupte, ... British journal of haematology 149 (5), 693-705, 2010 | 220 | 2010 |
| Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell … F Morschhauser, T Illidge, D Huglo, G Martinelli, G Paganelli, PL Zinzani, ... Blood, The Journal of the American Society of Hematology 110 (1), 54-58, 2007 | 208 | 2007 |
| High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 … JW Sweetenham, AM Carella, G Taghipour, D Cunningham, R Marcus, ... Journal of Clinical Oncology 17 (10), 3101-3109, 1999 | 204 | 1999 |
